Ligand density determines the efficiency of negative selection in the thymus

Citation
D. Romermann et al., Ligand density determines the efficiency of negative selection in the thymus, TRANSPLANT, 72(2), 2001, pp. 305-311
Citations number
35
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
TRANSPLANTATION
ISSN journal
00411337 → ACNP
Volume
72
Issue
2
Year of publication
2001
Pages
305 - 311
Database
ISI
SICI code
0041-1337(20010727)72:2<305:LDDTEO>2.0.ZU;2-4
Abstract
To study the influence of antigen density on the efficiency of negative sel ection in the thymus, MHC class I (H-2K(b), K-b) transgenic mice were gener ated, which expressed a K-b transgene under the control of its natural prom oter at 33% (Kb-lo) or 150% (Kb-hi) the surface density of K-b in C57BL/6 ( B6, H-2(b)) mice. These mice were crossed to anti-Kb T-cell receptor (Des-T CR) transgenic mice. In Des-TCRxK(b-hi) double transgenic mice, Des-TCR bea ring T cells were completely eliminated during thymocyte maturation. In con trast, in Des-TCRxK(b-lo) double transgenic mice, two populations of Des-TC R T cells were evident, which either expressed the Des-TCR at intermediate density in the absence of CD8 (Des-TCR(int)CD8(-)) or expressed both the De s-TCR and CD8 at low density (Des-TCR(lo)CD8(lo)). In the thymus of both ty pes of double transgenic mice, no Des-TCR(+)CD4(+)CD8(+) thymocytes were de tected, suggesting that deletion of Des-TCR cells occurred before the CD4()CD8(+) stage. Because only very few Des-TCR+ thymocytes were found in Des- TCRxK(b-hi) transgenic mice, deletion of these T cells apparently occurred upon expression of the Des-TCR. By contrast, Des-TCRxK(b-lo) transgenic mic e showed distinct populations of Des-TCR(int)CD4(-)8(-) and Des-TCR(int)CD8 (lo) thymocytes, suggesting that expression of the CD8 coreceptor was requi red to allow negative selection to proceed. Functional analyses showed that sublethally irradiated Des-TCRxK(b-lo) double transgenic mice were protect ed from lethal graft-versus-host disease by injected Des-TCR lymph node cel ls.